Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-Schedule vs Symptom-Triggered Therapy for AWS
NCT00136617Phase 3Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Aug 2003
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Chlordiazepoxide in alcohol withdrawal syndrome (AWS) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoints: Time to Short Alcohol Withdrawal Scale score below 12, Incidence of Seizures and Delirium Tremens and 4 more. Started Aug 2003; status: completed.
02
Drugs
Chlordiazepoxide
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT00136617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136617.